Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis

Oral Oncology

Volumn 48, Issue 9, 2012, Pages 761-767

  Zhao, Zhigang ^a   Ge, Jie ^a   Sun, Yanan ^a   Tian, Linli ^a   Lu, Jianguang ^a   Liu, Ming ^a   Zhao, Yashuang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cadherins; Head and neck neoplasms; Immunohistochemistry; Meta analysis; Prognosis; Systematic review

Indexed keywords

UVOMORULIN;

CANCER LOCALIZATION; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HAZARD RATIO; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RACE DIFFERENCE; REVIEW; SYSTEMATIC REVIEW;

CADHERINS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865160754     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.02.024     Document Type: Review

References (49)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. L. Cerezo, I. Millan, A. Torre, G. Aragon, and J. Otero Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases Cancer 69 5 1992 1224 1234
3. M. Remacle, M. Hamoir, E. Marbaix, N. Deggouj, and Y. Frederickx Interest in frozen section examination of margins and lymph nodes in laryngeal surgery J Laryngol Otol 102 9 1988 818 821
4. R.J. Kau, C. Alexiou, H. Stimmer, and W. Arnold Diagnostic procedures for detection of lymph node metastases in cancer of the larynx ORL J Otorhinolaryngol Relat Spec 62 4 2000 199 203 (Pubitemid 30414977)
5. S. Eidelman, C.H. Damsky, M.J. Wheelock, and I. Damjanov Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors Am J Pathol 135 1 1989 101 110 (Pubitemid 19228995)
6. M. Takeichi Cadherins: a molecular family important in selective cell-cell adhesion Annu Rev Biochem 59 1990 237 252
7. M. Takeichi Cadherin cell adhesion receptors as a morphogenetic regulator Science 251 5000 1991 1451 1455 (Pubitemid 121000430)
8. J.H. Schipper, U.H. Frixen, J. Behrens, A. Unger, K. Jahnke, and W. Birchmeier E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis Cancer Res 51 23 Pt 1 1991 6328 6337
9. J. Behrens, M.M. Mareel, F.M. Van Roy, and W. Birchmeier Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion J Cell Biol 108 6 1989 2435 2447 (Pubitemid 19168932)
10. J. Lim, J.H. Kim, J.Y. Paeng, M.J. Kim, S.D. Hong, and J.I. Lee Prognostic value of activated Akt expression in oral squamous cell carcinoma J Clin Pathol 58 11 2005 1199 1205 (Pubitemid 41566467)
11. J. Zou, H. Yang, F. Chen, H. Zhao, P. Lin, and J. Zhang Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma Eur J Cancer Prev 19 1 2010 11 17
12. L.K. Liu, X.Y. Jiang, X.X. Zhou, D.M. Wang, X.L. Song, and H.B. Jiang Upregulation of vimentin and aberrant expression of E-cadherin/B-catenin complex in oral squamous cell carcinomas Correlation with the clinicopathological features and patient outcome Mod Pathol 23 2 2010 213 224
13. F.C.A. de Aguiar, L.P. Kowalski, and O.P. de Almeida Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence Oral Oncol 43 6 2007 593 601 (Pubitemid 46856268)
14. K.A. Kurtz, H.T. Hoffman, M.B. Zimmerman, and R.A. Robinson Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas Otolaryngol Head Neck Surg 134 1 2006 142 146 (Pubitemid 43042327)
15. K.F. Hung, C.S. Chang, C.J. Liu, M.T. Lui, C.Y. Cheng, and S.Y. Kao Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma J Oral Pathol Med 35 10 2006 589 594
16. F.X. Bosch, C. Andl, U. Abel, and J. Kartenbeck E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma a comparison of E-cadherin with desmosomal components Int J Cancer 114 5 2005 779 790 (Pubitemid 40344439)
17. E. Steels, M. Paesmans, T. Berghmans, F. Branle, F. Lemaitre, and C. Mascaux Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur Respir J 18 4 2001 705 719 (Pubitemid 33040631)
18. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 24 1998 2815 2834 (Pubitemid 28562978)
19. M. Diniz-Freitas, T. Garcia-Caballero, J. Antunez-Lopez, J.M. Gandara-Rey, and A. Garcia-Garcia Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma Oral Oncol 42 2 2006 190 200 (Pubitemid 43106884)
20. J.F. Tierney, L.A. Stewart, D. Ghersi, S. Burdett, and M.R. Sydes Practical methods for incorporating summary time-to-event data into meta-analysis Trials 8 1 2007 16
21. Y. Hayashino, Y. Noguchi, and T. Fukui Systematic evaluation and comparison of statistical tests for publication bias J Epidemiol 15 6 2005 235 243 (Pubitemid 41715789)
22. M. Vered, A. Dobriyan, D. Dayan, R. Yahalom, Y.P. Talmi, and L. Bedrin Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer Cancer Sci 101 1 2010 274 280
23. E. Zvrko, A. Mikic, L. Vuckovic, M. Knezevic, and V. Djukic The study of E-cadherin expression in glottic laryngeal squamous cell carcinoma Serb J Exp Clin Res 10 3 2009 89 94
24. M.P. Wong, M. Cheang, E. Yorida, A. Coldman, C.B. Gilks, and D. Huntsman Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients Pathology 40 6 2008 611 616
25. H. Muramatsu, T. Akimoto, K. Maebayashi, M. Kita, and N. Mitsuhashi Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy Anticancer Res 28 6B 2008 3859 3864
26. S. Muller, L. Su, M. Tighiouart, N. Saba, H. Zhang, and D.M. Shin Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation Cancer 113 1 2008 97 107 (Pubitemid 351976391)
27. L.P. Zhong, J. Li, C.P. Zhang, H.G. Zhu, J. Sun, and Z.Y. Zhang Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients Arch Oral Biol 52 8 2007 740 747 (Pubitemid 46898958)
28. S.W. Pyo, M. Hashimoto, Y.S. Kim, C.H. Kim, S.H. Lee, and K.R. Johnson Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma correlation with the clinicopathologic features and patient outcome J Craniomaxillofac Surg 35 1 2007 1 9
29. G. Ueda, H. Sunakawa, K. Nakamori, T. Shinya, W. Tsuhako, and Y. Tamura Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma Int J Oral Maxillofac Surg 35 4 2006 356 361 (Pubitemid 43286269)
30. J.P. Rodrigo, F. Dominguez, C. Alvarez, C. Manrique, A. Herrero, and C. Suarez Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features Eur J Cancer 38 8 2002 1059 1064 (Pubitemid 34468010)
31. A. Bankfalvi, M. Krassort, A. Vegh, E. Felszeghy, and J. Piffko Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas J Oral Pathol Med 31 8 2002 450 457
32. V. Chow, A.P.W. Yuen, K.Y. Lam, G.S.W. Tsao, W.K. Ho, and W.I. Wei A comparative study of the clinicopathological significance of E-cadherin and catenins ((alpha), (beta), (gamma)) expression in the surgical management of oral tongue carcinoma J Cancer Res Clin Oncol Suppl 127 1 2001 59 63
33. J.J. Li, G.H. Zhang, X.M. Yang, S.S. Li, X. Liu, and Q.T. Yang Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma Auris Nasus Larynx 2011
34. Y. Nakanishi, S. Akimoto, Y. Sato, Y. Kanai, M. Sakamoto, and S. Hirohashi Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases Appl Immunohistochem Mol Morphol 12 4 2004 323 328 (Pubitemid 39602071)
35. X. Wang, J. Zhang, M. Fan, Q. Zhou, H. Deng, and M.J. Aisharif The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma immunohistochemical and RT-PCR analysis with clinicopathological correlation Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 4 2009 547 554
36. N.B. Jamieson, C.R. Carter, C.J. McKay, and K.A. Oien Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis Clin Cancer Res 17 10 2011 3316 3331
37. B.E.G. Rothberg, and M.B. Bracken E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis Breast Cancer Res Treat 100 2 2006 139 148 (Pubitemid 44631915)
38. V. Mattijssen, H.M. Peters, L. Schalkwijk, J.J. Manni, B. van 't Hof-Grootenboer, and P.H. de Mulder E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome Int J Cancer 55 4 1993 580 585 (Pubitemid 23328942)
39. J. Timar, O. Csuka, E. Remenar, G. Repassy, and M. Kasler Progression of head and neck squamous cell cancer Cancer Metastasis Rev 24 1 2005 107 127 (Pubitemid 40576067)
40. C.C. Ragin, S.M. Langevin, M. Marzouk, J. Grandis, and E. Taioli Determinants of head and neck cancer survival by race Head Neck J Sci Spec Head Neck 33 8 2011 1092 1098
41. K. Settle, M.R. Posner, L.M. Schumaker, M. Tan, M. Suntharalingam, and O. Goloubeva Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients Cancer Prev Res 2 9 2009 776 781
42. M.A. Molina, M.C. Cheung, E.A. Perez, M.M. Byrne, D. Franceschi, and F.L. Moffat African American and poor patients have a dramatically worse prognosis for head and neck cancer an examination of 20,915 patients Cancer 113 10 2008 2797 2806
43. F. Berthold, K. Sahin, B. Hero, H. Christiansen, M. Gehring, and D. Harms The current contribution of molecular factors to risk estimation in neuroblastoma patients Eur J Cancer 33 12 1997 2092 2097 (Pubitemid 28123462)
44. D.G. Altman Systematic reviews in health care - systematic reviews of evaluations of prognostic variables Brit Med J 323 7306 2001 224 228 (Pubitemid 32682099)
45. J.A. Hayden, P. Cote, and C. Bombardier Evaluation of the quality of prognosis studies in systematic reviews Ann Intern Med 144 6 2006 427 437 (Pubitemid 46768164)
46. P. Zhan, J. Wang, X.J. Lv, Q. Wang, L.X. Qiu, and X.Q. Lin Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis J Thorac Oncol 4 9 2009 1094 1103
47. G. Levidou, E. El-Habr, A.A. Saetta, C. Bamias, K. Katsouyanni, and E. Patsouris P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature J Neurooncol 100 3 2010 363 371
48. G. Supic, R. Kozomara, M. Brankovic-Magic, N. Jovic, and Z. Magic Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients Oral Oncol 45 12 2009 1051 1057
49. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, and G.M. Clark REporting recommendations for tumour MARKer prognostic studies (REMARK) Br J Cancer 93 4 2005 387 391 (Pubitemid 43080010)